The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen modulation.
Naphthalene compounds as selective estrogen receptor modulators
申请人:Glaxo Smith Kline LLC
公开号:US07649093B2
公开(公告)日:2010-01-19
The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.
[EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSES CHIMIQUES
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2006002185A1
公开(公告)日:2006-01-05
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.